[ad_1] Pfizer PFE, +0.75% is already laying the groundwork for what the pharmaceutical behemoth will…
Tag:
New Product Approvals
-
-
[ad_1] Biogen Inc.’s BIIB, +1.23% decision to let go of its CEO and scrap commercial…
-
STOCK MARKET
How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid
by userby user[ad_1] Gilead Sciences Inc. GILD, -0.29% has steadily expanded the use of Veklury while much…